Cite
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome.
MLA
Lewandowski, Konrad, et al. “The Effectiveness of Microencapsulated Sodium Butyrate at Reducing Symptoms in Patients with Irritable Bowel Syndrome.” Gastroenterology Review / Przegląd Gastroenterologiczny, vol. 17, no. 1, Jan. 2022, pp. 28–34. EBSCOhost, https://doi.org/10.5114/pg.2021.112681.
APA
Lewandowski, K., Kaniewska, M., Karłowicz, K., Rosołowski, M., & Rydzewska, G. (2022). The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome. Gastroenterology Review / Przegląd Gastroenterologiczny, 17(1), 28–34. https://doi.org/10.5114/pg.2021.112681
Chicago
Lewandowski, Konrad, Magdalena Kaniewska, Katarzyna Karłowicz, Mariusz Rosołowski, and Grażyna Rydzewska. 2022. “The Effectiveness of Microencapsulated Sodium Butyrate at Reducing Symptoms in Patients with Irritable Bowel Syndrome.” Gastroenterology Review / Przegląd Gastroenterologiczny 17 (1): 28–34. doi:10.5114/pg.2021.112681.